Literature DB >> 8785024

Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects.

S S Wolf1, T M Hyde, R C Saunders, M M Herman, D R Weinberger, J E Kleinman.   

Abstract

Neurotensin, an endogenous peptide and putative neurotransmitter, exhibits a wide range of interactions with dopaminergic neurons and displays some actions akin to neuroleptics. Moreover, neurotensin receptors are abundant in specific layers of the entorhinal cortex where cytoarchitectural abnormalities have been reported in schizophrenia. We therefore examined the entorhinal cortex from postmortem specimens of five control patients and six schizophrenic patients for alterations in neurotensin receptor quantitation and distribution using receptor autoradiography. Specific 125I- neurotensin binding was concentrated in layer II cell clusters, with a 40% reduction in binding in the schizophrenic group (p < 0.05). Moderate binding was observed in both cohorts in deep layers V/VI, with negligible binding in the hippocampus. There was no statistical difference in quantitative neurotensin binding in other lamina of the entorhinal cortex of schizophrenics compared with controls. The characteristic laminar pattern of binding did not differ between cohorts. The reduction in neurotensin binding in schizophrenics is consistent with an increasing number of reports of structural abnormalities in the medial temporal lobe of schizophrenics in general and the entorhinal cortex in particular. Further studies are required to examine the evidence for neuroanatomic and neurochemical pathology in the entorhinal cortex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8785024     DOI: 10.1007/bf01276565

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  38 in total

1.  Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections.

Authors:  G W Van Hoesen; D N Pandya
Journal:  Brain Res       Date:  1975-09-12       Impact factor: 3.252

2.  Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.

Authors:  J N Joyce; A Janowsky; K A Neve
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

3.  Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.

Authors:  S E Arnold; V M Lee; R E Gur; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.

Authors:  K L Jansen; R L Faull; M Dragunow; B L Synek
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

5.  A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal, and perirhinal cortices.

Authors:  R C Saunders; D L Rosene
Journal:  J Comp Neurol       Date:  1988-05-08       Impact factor: 3.215

6.  Binding of [3H]neurotensin in human brain: properties and distribution.

Authors:  K S Kanba; S Kanba; H Okazaki; E Richelson
Journal:  J Neurochem       Date:  1986-03       Impact factor: 5.372

7.  Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia.

Authors:  J M Palacios; G Chinaglia; M Rigo; J Ulrich; A Probst
Journal:  Synapse       Date:  1991-02       Impact factor: 2.562

8.  Autoradiographic characterization of 125I-neurotensin binding sites in human entorhinal cortex.

Authors:  S S Wolf; T M Hyde; T W Moody; R C Saunders; D R Weinberger; J E Kleinman
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

9.  Neurotensin in the human brain.

Authors:  J K Mai; J Triepel; J Metz
Journal:  Neuroscience       Date:  1987-08       Impact factor: 3.590

Review 10.  Gross and histological criteria for developmental disorders in brains of schizophrenics.

Authors:  H Jakob; H Beckmann
Journal:  J R Soc Med       Date:  1989-08       Impact factor: 18.000

View more
  9 in total

Review 1.  Neurotensin agonists: potential in the treatment of schizophrenia.

Authors:  Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Antipsychotic-like effects of a neurotensin receptor type 1 agonist.

Authors:  Chelsea A Vadnie; Jennifer Ayers-Ringler; Alfredo Oliveros; Osama A Abulseoud; Sun Choi; Mario J Hitschfeld; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2016-02-22       Impact factor: 3.332

3.  Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

Authors:  Harry Pantazopoulos; Nicholas Lange; Ross J Baldessarini; Sabina Berretta
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

4.  Association between neurotensin receptor 1 (NTR1) gene polymorphisms and schizophrenia in a Han Chinese population.

Authors:  Hui Ma; Yinglin Huang; Bo Zhang; Jingying Li; Yuan Wang; Xiaofeng Zhao; Qiu Jin; Gang Zhu
Journal:  J Mol Neurosci       Date:  2013-03-13       Impact factor: 3.444

5.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

6.  Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease model.

Authors:  Zhaoyang Xiao; Nicholas I Cilz; Lalitha Kurada; Binqi Hu; Chuanxiu Yang; Etsuko Wada; Colin K Combs; James E Porter; Florian Lesage; Saobo Lei
Journal:  J Neurosci       Date:  2014-05-14       Impact factor: 6.167

7.  Analysis of the transcriptional activity of genes of neuropeptides and their receptors in the blood of patients with thyroid pathology.

Authors:  Iryna Ivanivna Kamyshna; Larysa Borysivna Pavlovych; Vitaliy Antonovych Maslyanko; Aleksandr Mychailovich Kamyshnyi
Journal:  J Med Life       Date:  2021 Mar-Apr

8.  CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin.

Authors:  Parichehr Hassanzadeh; Fatemeh Rostami
Journal:  Iran J Basic Med Sci       Date:  2014-03       Impact factor: 2.699

9.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.